23 July 2020 | News
Collaboration paves the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders
Image credit- shutterstock.com
IQVIA™ has announced it is joining forces with US based JDRF, the leading global organization funding type 1 diabetes (T1D) research, to use non-identified patient-level, real world data and analytics to address unmet needs in the diabetes community.
The IQVIA-JDRF collaboration will utilize non-identified real world data to answer important clinical research questions and address areas of unmet need in people with T1D, including how to improve diagnostic accuracy, assess the impact of treatments and monitoring devices on outcomes, and optimize future drug development efforts. In the first project, the team is collaborating to help improve distinctions in diagnosing type 1 vs. type 2 or other diabetes.
It is estimated that nearly 40 percent of people with adult-onset T1D may be initially misdiagnosed, so helping differentiate diabetes types will better ensure appropriate treatment and patient outcomes.
By combining advanced analytics with unparalleled data and deep domain expertise, IQVIA can support JDRF’s vision to tackle unanswered research questions to move both the care and eventual cure of diabetes forward in people of all ages.